ArticleEmerging microbes & infections2023

Application of "B+1" heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines.

Zezhong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.